We investigated naturally occurring variation within the major (L1) and minor (L2) capsid proteins of human papillomavirus genotype 45 (HPV45). Pseudoviruses (PsVs) representing HPV45 sublineages A1, A2, A3, B1, and B2 exhibited comparable particle- to-infectivity ratios and morphologies but demonstrated both increased (A2, A3, and B1) and decreased (B2) sensitivities to cross-neutralization by HPV vaccine antibodies compared to that of the A1 sublineage. Mutant PsVs identified HI loop residue 357 as being critical for conferring this differential sensitivity.

Godi, A., Facchetti, A., Bissett, S., Cocuzza, C., Miller, E., Beddows, S. (2016). Naturally occurring major and minor capsid protein variants of human papillomavirus 45 (HPV45): Differential recognition by cross-neutralizing antibodies generated by HPV vaccines. JOURNAL OF VIROLOGY, 90(6), 3247-3252 [10.1128/JVI.02859-15].

Naturally occurring major and minor capsid protein variants of human papillomavirus 45 (HPV45): Differential recognition by cross-neutralizing antibodies generated by HPV vaccines

COCUZZA, CLEMENTINA ELVEZIA;
2016

Abstract

We investigated naturally occurring variation within the major (L1) and minor (L2) capsid proteins of human papillomavirus genotype 45 (HPV45). Pseudoviruses (PsVs) representing HPV45 sublineages A1, A2, A3, B1, and B2 exhibited comparable particle- to-infectivity ratios and morphologies but demonstrated both increased (A2, A3, and B1) and decreased (B2) sensitivities to cross-neutralization by HPV vaccine antibodies compared to that of the A1 sublineage. Mutant PsVs identified HI loop residue 357 as being critical for conferring this differential sensitivity.
Articolo in rivista - Articolo scientifico
HPV 45 capsid proteins, Human Papilloma Virus, immunity
English
26-feb-2016
2016
90
6
3247
3252
open
Godi, A., Facchetti, A., Bissett, S., Cocuzza, C., Miller, E., Beddows, S. (2016). Naturally occurring major and minor capsid protein variants of human papillomavirus 45 (HPV45): Differential recognition by cross-neutralizing antibodies generated by HPV vaccines. JOURNAL OF VIROLOGY, 90(6), 3247-3252 [10.1128/JVI.02859-15].
File in questo prodotto:
File Dimensione Formato  
10281-103662.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 2.1 MB
Formato Adobe PDF
2.1 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/103662
Citazioni
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
Social impact